Genetic diversity of human erythroviruses. Consequences on infectious safety of plasma derivatives;Impact de la diversité génétique des erythrovirus humains sur la sécurité infectieuse des médicaments dérivés du sang

Transfusion Clinique et Biologique

Volumn 16, Issue 5-6, 2009, Pages 482-488

  Servant Delmas, A ^a   Mercier, M ^a   Laperche, S ^a   Lefrere J J ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

B19 Parvovirus; Genetic diversity; Genotypes; Plasma derivatives

Indexed keywords

BLOOD DERIVATIVE; VIRUS DNA;

BLOOD TRANSFUSION; ERYTHROCYTE LIFESPAN; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOCOMPROMISED PATIENT; NEW SPECIES; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PHYLOGENY; PREGNANT WOMAN; PROGNOSIS; SAFETY; SEROPREVALENCE; SHORT SURVEY; VIRUS DETECTION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS VIRULENCE;

BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; DNA, VIRAL; ERYTHROVIRUS; GENETIC VARIATION; HUMANS; IMMUNOCOMPROMISED HOST; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PLASMA;

EID: 71049151498     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2009.09.001     Document Type: Short Survey

References (50)

1. Cossart Y.E., Field A.M., Cant B., and Widdows D. Parvovirus-like particles in human sera. Lancet 1 (1975) 72-73
2. Agbandje-McKenna M., and Rossmann M.G. The structure of human parvovirus B19. In: Anderson L.J., and Young N.S. (Eds). Human Parvovirus B19. First ed. 20 (1997), Karger, New York 3-15
3. Siegl G., Bates R.C., Berns K.I., Carter B.J., Kelly D.C., Kurstak E., et al. Characteristics and taxonomy of Parvoviridae. Intervirology 23 (1985) 61-73
4. Brown K.E., Anderson S.M., and Young N.S. Erythrocyte P antigen: cellular receptor for B19 Parvovirus. Science 262 (1993) 114-117
5. Weigel-Kelley K.A., Yoder M.C., and Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human Parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102 (2003) 3927-3933
6. Munakata Y., Saito-Ito T., Kumura-Ishii K., Huang J., Kodera T., Ishii T., et al. Ku80 autoantigen as a cellular coreceptor for human Parvovirus B19 infection. Blood 106 (2005) 3449-3456
7. Mortimer P.P., Humphries R.K., Moore J.G., Purcell R.H., and Young N.S. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302 (1983) 426-429
8. Young N.S., and Brown K.E. Parvovirus B19. N Engl J Med 350 (2004) 586-597
9. Kurtzman G.J., Cohen B.J., Field A.M., Oseas R., Blaese R.M., and Young N.S. Immune response to B19 Parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84 (1989) 1114-1123
10. Parsyan A., and Candotti D. Human erythrovirus B19 and blood transfusion - an update. Transfus Med 17 (2007) 263-278
11. Candotti D., Etiz N., Parsyan A., and Allain J.P. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 78 (2004) 12169-12178
12. Lefrere J.J., Servant-Delmas A., Candotti D., Mariotti M., Thomas I., Brossard Y., et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 106 (2005) 2890-2895
13. Cassinotti P., Burtonboy G., Fopp M., and Siegl G. Evidence for persistence of human Parvovirus B19 DNA in bone marrow. J Med Virol 53 (1997) 229-232
14. Norja P., Hokynar K., Aaltonen L.M., Chen R., Ranki A., Partio E.K., et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 103 (2006) 7450-7453
15. Brown K.E., and Simmonds P. Parvoviruses and blood transfusion. Transfusion 47 (2007) 1745-1750
16. Thomas I., Di Giambattista M., Gerard C., Mathys E., Hougardy V., Latour B., et al. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang 84 (2003) 300-307
17. Schmidt M., Themann A., Drexler C., Bayer M., Lanzer G., Menichetti E., et al. Blood donor screening for Parvovirus B19 in Germany and Austria. Transfusion 47 (2007) 1775-1782
18. Kleinman S.H., Glynn S.A., Lee T.H., Tobler L., Montalvo L., Todd D., et al. Prevalence and quantitation of Parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 47 (2007) 1756-1764
19. Flan B., Visse C., and Aubin J.T. Apport des techniques d'amplification des acides nucléiques viraux au contrôle de qualité du plasma pour fractionnement. Virologie 9 (2005) S25-S35
20. Cohen B.J., Beard S., Knowles W.A., Ellis J.S., Joske D., Goldman J.M., et al. Chronic anemia due to Parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 37 (1997) 947-952
21. Zanella A., Rossi F., Cesana C., Foresti A., Nador F., Binda A.S., et al. Transfusion-transmitted human Parvovirus B19 infection in a thalassemic patient. Transfusion 35 (1995) 769-772
22. Servant A., Laperche S., Lallemand F., Marinho V., De Saint Maur G., Meritet J.F., et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76 (2002) 9124-9134
23. Parsyan A., Szmaragd C., Allain J.P., and Candotti D. Identification and genetic diversity of two human Parvovirus B19 genotype 3 subtypes. J Gen Virol 88 (2007) 428-431
24. Hokynar K., Brunstein J., Soderlund-Venermo M., Kiviluoto O., Partio E.K., Konttinen Y., et al. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol 81 (2000) 1017-1025
25. Lukashov V.V., and Goudsmit J. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. J Virol 75 (2001) 2729-2740
26. Saikawa T., Anderson S., Momoeda M., Kajigaya S., and Young N.S. Neutralizing linear epitopes of B19 Parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 67 (1993) 3004-3009
27. Hemauer A., von Poblotzki A., Gigler A., Cassinotti P., Siegl G., Wolf H., et al. Sequence variability among different Parvovirus B19 isolates. J Gen Virol 77 (1996) 1781-1785
28. Nguyen Q.T., Sifer C., Schneider V., Bernaudin F., Auguste V., and Garbarg-Chenon A. Detection of an erythrovirus sequence distinct from B19 in a child with acute anemia. Lancet 352 (1998) 1524
29. Hokynar K., Soderlund-Venermo M., Pesonen M., Ranki A., Kiviluoto O., Partio E.K., et al. A new parvovirus genotype persistent in skin. Virology 302 (2002) 224-228
30. Nguyen Q.T., Wong S., Heegaard E.D., and Brown K.E. Identification of a second novel human erythrovirus variant, A6. Virology 301 (2002) 374-380
31. Wong S., Young N.S., and Brown K.E. Prevalence of Parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 187 (2003) 1581-1586
32. Sanabani S., Neto W.K., Pereira J., and Sabino E.C. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various Parvovirus B19-related hematological symptoms. J Clin Microbiol 44 (2006) 604-606
33. Schneider B., Hone A., Tolba R.H., Fischer H.P., Blumel J., and Eis-Hubinger A.M. Simultaneous persistence of multiple genome variants of human Parvovirus B19. J Gen Virol 89 (2008) 164-176
34. Kuhl U., Lassner D., Pauschinger M., Gross U.M., Seeberg B., Noutsias M., et al. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol 80 (2008) 1243-1251
35. Hokynar K., Norja P., Laitinen H., Palomaki P., Garbarg-Chenon A., Ranki A., et al. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol 42 (2004) 2013-2019
36. Schneider B., Becker M., Brackmann H.H., and Eis-Hubinger A.M. Contamination of coagulation factor concentrates with human Parvovirus B19 genotype 1 and 2. Thromb Haemost 92 (2004) 838-845
37. Koppelman M.H., Rood I.G., Fryer J.F., Baylis S.A., and Cuypers H.T. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays. Vox Sang 93 (2007) 208-215
38. Parsyan A., Kerr S., Owusu-Ofori S., Elliott G., and Allain J.P. Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol 44 (2006) 1367-1375
39. Heegaard E.D., Qvortrup K., and Christensen J. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19. J Med Virol 66 (2002) 246-252
40. Corcoran A., Doyle S., Allain J.P., Candotti D., and Parsyan A. Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections. J Virol 79 (2005) 5238-5239 author reply 5239
41. Ekman A., Hokynar K., Kakkola L., Kantola K., Hedman L., Bondén H., et al. Biological and immunological relations among human Parvovirus B19 genotypes 1 to 3. J Virol 81 (2007) 6927-6935
42. Baylis S.A., Shah N., and Minor P.D. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J Virol Methods 121 (2004) 7-16
43. Baylis S.A. Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: a meeting summary. Vox Sang 94 (2008) 74-80
44. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., and Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 102 (2005) 12891-12896
45. Manning A., Russell V., Eastick K., Leadbetter G.H., Hallam N., Templeton K., et al. Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis 194 (2006) 1283-1290
46. Jones M.S., Kapoor A., Lukashov V.V., Simmonds P., Hecht F., and Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 79 (2005) 8230-8236
47. Simmonds P., Douglas J., Bestetti G., Longhi E., Antinori S., Parravicini C., et al. A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol 89 (2008) 2299-2302
48. Fryer J.F., Delwart E., Hecht F.M., Bernardin F., Jones M.S., Shah N., et al. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 47 (2007) 1054-1061
49. Servant-Delmas A., Laperche S., Mercier M., Elghouzzi M.H., Lionnet F., Stankovic K., et al. Human parvovirus 4 in recipients of cellular products and in blood donors: epidemiologic similarity with B19 parvovirus. Transfusion 49 (2009) 1771-1772
50. In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L.A. (Eds). Virus taxonomy: 8th report of the International Committee on Taxonomy of Viruses (2005), Elsevier, London, UK